Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02907944 · ClinicalTrials.gov registry record · NA
Working With HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 3,838
- Enrollment target
NCT02907944 is a NA study that has completed, run by Yale University. The registered enrollment target is 3,838 participants.
The verdict
NCT02907944, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,838 participants
- Enrollment target
Study Summary
Tobacco, alcohol and opioid use disorders threaten the health of HIV-infected patients. What if evidence-based counseling and medication treatments for tobacco, alcohol and opioid use disorders (herein refered to as addiction treatments) were routinely provided in HIV clinics? Implementation Facilitation is an established strategy to increase the uptake of evidence-based treatments. Our goal is to evaluate the impact of Implementation Facilitation on the use of addiction treatments in four large HIV clinics. The purpose of the WHAT-IF study is: Aim 1. Among key stakeholders, to use quantitative and qualitative (mixed) methods to identify the site-specific evidence, context and facilitation-related barriers and facilitators to the integration of addiction treatments to help tailor an Implementation Facilitation for each clinic. Aim 2. To evaluate the impact of Implementation Facilitation on: 2a: Organizational readiness to deliver addiction treatments 2b: Provider readiness to deliver addiction treatments 2c: Provision of addiction treatments 2d: Changes in organizational models of care used to deliver addiction treatments Aim 3. To evaluate the impact of Implementation Facilitation on antiretroviral therapy receipt, HIV viral suppression, VACS Index, and retention in HIV care among patients eligible for addiction treatment.
Interventions
- BEHAVIORAL Implementation Facilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,838 participants |
| Start Date | 2016-09 |
| Est. Completion | 2021-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02907944
The ClinicalTrials.gov registry entry for NCT02907944 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,838 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Implementation Facilitation is the first listed.
NCT02907944 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02907944 about?
NCT02907944 is a clinical study titled "Working With HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation". Tobacco, alcohol and opioid use disorders threaten the health of HIV-infected patients. What if evidence-based counseling and medication treatments for tobacco, alcohol and opioid use disorders (herein refered to as addiction treatments) were routinely provided in HIV clinics? Implementation Facilit...
What is the current status of trial NCT02907944?
This trial is currently completed. It is a NA study. The enrollment target is 3,838 participants. The study started on 2016-09. Estimated completion is 2021-09-30.
What interventions are being tested in trial NCT02907944?
The interventions under investigation include: Implementation Facilitation (BEHAVIORAL).
Who is sponsoring clinical trial NCT02907944?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.